Issue Date: December 10, 2012
AMRI Realigns Its Discovery Services
Albany Molecular Research Inc. will fold its in vitro biology capabilities into its other drug discovery services. In the process, the firm will close its Bothell, Wash., site, which employs 24 people, by March 2013. The company will move most of the site’s activities to its Singapore location and certain analytical capabilities to its Albany headquarters. Earlier this year, AMRI trimmed its U.S. contract drug discovery staff, closed a site in Hungary, and expanded in India and Singapore.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society